<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/26/5000D" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/26/5000D/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/26/5000D/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_5000D"><akn:num>5000D</akn:num><akn:heading>Designated drugs during noncompliance periods</akn:heading><akn:content><akn:p>§ 5000D. Designated drugs during noncompliance periods(a) In generalThere is hereby imposed on the sale by the manufacturer, producer, or importer of any designated drug during a day described in subsection (b) a tax in an amount such that the applicable percentage is equal to the ratio of—(1) such tax, divided by

(2) the sum of such tax and the price for which so sold.


(b) Noncompliance periodsA day is described in this subsection with respect to a designated drug if it is a day during one of the following periods:(1) The period beginning on the March 1st (or, in the case of initial price applicability year 2026, the October 2nd) immediately following the date on which such drug is included on the list published under section 1192(a) of the Social Security Act and ending on the earlier of—(A) the first date on which the manufacturer of such designated drug has in place an agreement described in section 1193(a) of such Act with respect to such drug, or

(B) the date that the Secretary of Health and Human Services has made a determination described in section 1192(c)(1) of such Act with respect to such designated drug.


(2) The period beginning on the November 2nd immediately following the March 1st described in paragraph (1) (or, in the case of initial price applicability year 2026, the August 2nd immediately following the October 2nd described in such paragraph) and ending on the earlier of—(A) the first date on which the manufacturer of such designated drug and the Secretary of Health and Human Services have agreed to a maximum fair price under an agreement described in section 1193(a) of the Social Security Act, or

(B) the date that the Secretary of Health and Human Services has made a determination described in section 1192(c)(1) of such Act with respect to such designated drug.


(3) In the case of any designated drug which is a selected drug (as defined in section 1192(c) of the Social Security Act) that the Secretary of Health and Human Services has sele</akn:p></akn:content><akn:subsection eId="subsec_5000D_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general There is hereby imposed on the sale by the manufacturer, producer, or importer of any designated drug during a day described in subsection (b) a tax in an amount such that the applicable percentage is equal to the ratio of—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_5000D_b"><akn:num>(b)</akn:num><akn:heading>Noncompliance periods</akn:heading><akn:content><akn:p>(b) Noncompliance periods A day is described in this subsection with respect to a designated drug if it is a day during one of the following periods:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_5000D_c"><akn:num>(c)</akn:num><akn:heading>Suspension of tax</akn:heading><akn:content><akn:p>(c) Suspension of tax</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_5000D_d"><akn:num>(d)</akn:num><akn:heading>Applicable percentage</akn:heading><akn:content><akn:p>(d) Applicable percentage For purposes of this section, the term “applicable percentage” means—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_5000D_e"><akn:num>(e)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(e) Definitions For purposes of this section—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_5000D_f"><akn:num>(f)</akn:num><akn:heading>Special rules</akn:heading><akn:content><akn:p>(f) Special rules</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_5000D_g"><akn:num>(g)</akn:num><akn:heading>Exports</akn:heading><akn:content><akn:p>(g) Exports Rules similar to the rules of section 4662(e) (other than section 4662(e)(2)(A)(ii)(II)) shall apply for purposes of this chapter.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_5000D_h"><akn:num>(h)</akn:num><akn:heading>Regulations</akn:heading><akn:content><akn:p>(h) Regulations The Secretary shall prescribe such regulations and other guidance as may be necessary to carry out this section.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>